BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CASL - Canadian Association for the Study of the Liver - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://hepatology.ca
X-WR-CALDESC:Events for CASL - Canadian Association for the Study of the Liver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251025
DTEND;VALUE=DATE:20251027
DTSTAMP:20260531T004608
CREATED:20250520T161325Z
LAST-MODIFIED:20250520T161640Z
UID:4729-1761350400-1761523199@hepatology.ca
SUMMARY:2025 Advancing Diversity\, Equity & Inclusion in Transplantation: A Global Perspective Conference
DESCRIPTION:The 2025 Advancing Diversity\, Equity & Inclusion in Transplantation: A Global Perspective Conference is a groundbreaking event hosted by the Ajmera Transplant Center in Toronto. The conference\, scheduled for October 25-26\, 2025\, brings together international transplant leaders\, clinicians\, surgeons\, nurses\, researchers\, policymakers\, and representatives from academic and community-based organizations. \nThe conference aims to address the critical challenges faced by transplant providers and patients in achieving diversity\, equity\, and inclusion (DEI) across all organ groups. It emphasizes a patient-centric approach\, ensuring that the voices and needs of patients and caregivers are central to the discussions. Attendees will have the opportunity to engage with notable speakers\, explore DEI challenges\, and contribute to a global dialogue on advancing DEI in transplantation. \nThis second edition will be co-located with the 6th Congress of International Advanced HBP Surgery (ISLS 2025) featuring a Joint Session with Keynote Speaker Dr. Nouman Ashraf addressing “Enabling Exemplary Care Through Behavioural Empathy.” \nAttendees of the Advancing Diversity\, Equity & Inclusion in Transplantation: A Global Perspective Conference will receive a discount to attend ISLS 2025. \n> LEARN MORE < \n \n 
URL:https://hepatology.ca/event/2025-advancing-diversity-equity-inclusion-in-transplantation-a-global-perspective-conference/
LOCATION:Sheraton Centre Toronto Hotel\, 123 Queen St W\, Toronto\, Ontario\, Canada
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251022T080000
DTEND;TZID=UTC:20251025T170000
DTSTAMP:20260531T004608
CREATED:20241209T214458Z
LAST-MODIFIED:20250106T151241Z
UID:4543-1761120000-1761411600@hepatology.ca
SUMMARY:The 6th Congress of International Advanced HBP Surgery
DESCRIPTION:The 6th Congress of International Advanced HBP Surgery will be held from October 22 to 25\, 2025\, at the Sheraton Centre Toronto Hotel in Canada. This prestigious event\, organized by the International Society of Liver Surgeons (ISLS)\, brings together leading experts in hepatobiliary and pancreatic (HBP) surgery from around the world. \n \nThe congress will feature a diverse scientific program\, including keynote lectures\, free paper presentations\, and interactive sessions. Attendees will have the opportunity to engage with cutting-edge research\, innovative surgical techniques\, and the latest advancements in HBP surgery. This biennial event is a must-attend for professionals seeking to enhance their knowledge and network with peers in the field. \nFor more details\, visit the official ISLS Congress website
URL:https://hepatology.ca/event/the-6th-congress-of-international-advanced-hbp-surgery/
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250920T113000
DTEND;TZID=America/Toronto:20250920T150000
DTSTAMP:20260531T004608
CREATED:20250827T175451Z
LAST-MODIFIED:20250827T175451Z
UID:4858-1758367800-1758380400@hepatology.ca
SUMMARY:Inaugural Canadian Hepatitis B Patient Forum: Bringing Patients Together
DESCRIPTION:Join us for the Inaugural Canadian Hepatitis B Patient Forum on September 20\, 2025 — a free virtual event bringing together patients\, caregivers\, and experts to share experiences and learn about Hepatitis B.\n 11:30 AM – 3:00 PM ET | In-Person in Toronto & Vancouver Site only\n️ Topics include treatment\, patient journeys\, liver cancer\, and more.\n Register now at canadianhbvnetwork.ca or chineseliversupportgroup.ca\n️ Interpretation available in Cantonese\, Mandarin\, Vietnamese\, and French.
URL:https://hepatology.ca/event/inaugural-canadian-hepatitis-b-patient-forum-bringing-patients-together/
LOCATION:Toronto\, Toronto\, Canada
CATEGORIES:Endorsed by CASL,In-Person
ORGANIZER;CN="Canadian HBV Network":MAILTO:canhepb@ucalgary.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250318T080000
DTEND;TZID=UTC:20250321T170000
DTSTAMP:20260531T004608
CREATED:20241209T214741Z
LAST-MODIFIED:20241209T214930Z
UID:4547-1742284800-1742576400@hepatology.ca
SUMMARY:Global Hepatitis Summit 2025
DESCRIPTION:The Global Hepatitis Summit 2025 will take place from March 18 to 21\, 2025\, at the Westin Bonaventure Hotel & Suites in Los Angeles\, USA. This event\, marking the 19th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD)\, will gather leading experts\, researchers\, and healthcare professionals from around the world to discuss the latest advancements in hepatitis research\, prevention\, diagnosis\, treatment\, and elimination. \n \nThe summit will feature a comprehensive program with plenary sessions\, parallel tracks\, and symposia covering various aspects of viral hepatitis\, including basic-translational science\, clinical science\, and public health. Attendees can expect to engage with cutting-edge research\, innovative therapies\, and public health strategies aimed at combating hepatitis B\, C\, and D. \nFor more information\, visit the official Global Hepatitis Summit website.
URL:https://hepatology.ca/event/global-hepatitis-summit-2025/
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20241128T180000
DTEND;TZID=America/Vancouver:20241128T193000
DTSTAMP:20260531T004608
CREATED:20241004T135938Z
LAST-MODIFIED:20241004T135938Z
UID:4427-1732816800-1732822200@hepatology.ca
SUMMARY:SHINE - Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies
DESCRIPTION:You are cordially invited to SHINE – Systemic Hepatocellular carcinoma: Incorporating New Emerging therapies. A multidisciplinary virtual case-based discussion comprised of leading experts across Western Canada. \nThurs Nov 28 2024\, 6-730 PST | 7-8:30 MST | 8-9:30 CST \n \n  \nPanelists \n\nDr Michael Bleszynski\, HPB Surgeon at Vancouver General Hospital – Vancouver\nDr Mayur Brahmania\, Hepatologist at University of Calgary and CASL’s Education Committee Co-Chair – Calgary\nDr Howard Lim\, Medical Oncologist at BC Cancer Agency – Vancouver\nDr Dave Liu\, Interventional Radiologist at University of British Columbia – Vancouver\nDr Maged Nashed\, Radiation Oncologist at University of Manitoba – Winnipeg\nDr Jennifer Spratlin\, Medical Oncologist at Cross Cancer Institute – Edmonton\nDr Vincent Tam\, Medical Oncologist at Tom Baker Cancer Centre – Calgary\n\nObjectives \n\nUnderstand the current treatment landscape of intermediate HCC.\nAnalyze the emerging role of systemic therapies in TACE/TARE-eligible intermediate HCC.\nDiscuss the use of systemic therapy prior to liver transplant for intermediate stage HCC\npatients.\nExamine future directions and emerging therapies/treatment strategies in intermediate HCC.\n\nPlease RSVP here: https://forms.office.com/e/7qf5GTXZXu
URL:https://hepatology.ca/event/shine-systemic-hepatocellular-carcinoma-incorporating-new-emerging-therapies/
LOCATION:Online
CATEGORIES:Endorsed by CASL,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241115
DTEND;VALUE=DATE:20241120
DTSTAMP:20260531T004608
CREATED:20241029T132127Z
LAST-MODIFIED:20241113T000617Z
UID:4421-1731628800-1732060799@hepatology.ca
SUMMARY:The 75th Liver Meeting | AASLD
DESCRIPTION:The 75th Liver Meeting is a global gathering you won’t want to miss! This is your opportunity to engage with other international partners dedicated to advancing liver health at #TLM24\, Nov. 15-19 in San Diego! For over seven decades\, this gathering has been the premier event for hepatology professionals worldwide to collaborate and share cutting-edge expertise. It’s not too late to register: https://www.aasld.org/the-liver-meeting
URL:https://hepatology.ca/event/the-75th-liver-meeting/
CATEGORIES:Endorsed by CASL,In-Person,Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241018T110000
DTEND;TZID=America/Halifax:20241019T170000
DTSTAMP:20260531T004608
CREATED:20240608T164853Z
LAST-MODIFIED:20240608T164937Z
UID:3892-1729249200-1729357200@hepatology.ca
SUMMARY:ILCA 2024 Annual Conference
DESCRIPTION:The 18th edition of the ILCA Annual Conference will be held in conjunction with the Canadian Association for the Study of the Liver (CASL) Single Topic Conference on HCC on 17-19 October in Toronto\, Canada\, promising yet another enriching and impactful gathering for the liver cancer community. \nConnect with inspiring liver cancer specialists through exceptional education and pioneering insights. \nJoin us in Toronto to unite minds and transform the landscape of liver cancer treatment and care.
URL:https://hepatology.ca/event/ilca-2024-annual-conference/
LOCATION:Hilton Toronto\, 145 Richmond Street West\, Toronto\, Ontario\, Canada
CATEGORIES:Endorsed by CASL
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240913
DTEND;VALUE=DATE:20240915
DTSTAMP:20260531T004608
CREATED:20240315T141833Z
LAST-MODIFIED:20240508T194138Z
UID:3513-1726185600-1726358399@hepatology.ca
SUMMARY:Advancing DEI in Transplantation: A Global Perspective
DESCRIPTION:Join us for the inaugural Advancing Diversity\, Equity & Inclusion in Transplantation: A Global Perspective conference\, hosted by the Ajmera Transplant Center in Toronto\, September 13 and 14. This groundbreaking event brings together International Transplant Leaders\, clinicians\, surgeons\, nurses\, researchers\, policy makers\, and representatives from academic and community-based organizations. \n \nKey Highlights: \n\nUnderstanding DEI Challenges: Explore the critical challenges faced by transplant providers and patients in achieving Diversity\, Equity\, and Inclusion (DEI) across organ groups.\nPatient-Centric Approach: Our focus centers on patients and caregivers\, ensuring their voices are heard and their needs addressed.\nNotable Speakers:\n\nNancy Ascher: A renowned transplant surgeon and advocate for equity in healthcare.\nNorah Terrault: An expert in liver transplantation and a champion for diversity and inclusion.\n\n\n\nAbstract Submission Open! Submit your abstract for poster presentation at the conference. Abstract submission deadline: May 1\, 2024. \nDon’t miss this unique opportunity to be part of a global dialogue on advancing DEI in transplantation. Learn more and register at deiintransplant.com.
URL:https://hepatology.ca/event/advancing-dei-in-transplantation-a-global-perspective/
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240509T080000
DTEND;TZID=UTC:20240509T170000
DTSTAMP:20260531T004608
CREATED:20240428T160326Z
LAST-MODIFIED:20240508T194153Z
UID:3553-1715241600-1715274000@hepatology.ca
SUMMARY:Canadian Viral Hepatitis Elimination Day
DESCRIPTION:On Thursday\, May 9\, 2024\, the Canadian Association for the Study of the Liver will join Action Hepatitis Canada\, CanHepC\, CanHepB\, and the Canadian Liver Foundation to mark the 3rd annual Canadian Viral Hepatitis Elimination Day in Ottawa. \n#CanHepDay24  #HepCantWait \nThank you to our many members and allies who are helping amplify our call for the federal government\, as well as each province and territory\, to bring urgency to eliminating viral hepatitis as a public health threat in Canada by 2030. \nFIVE FEDERAL ASKS \nIn 2016\, Canada made an international commitment to eliminate viral hepatitis as a public health threat by 2030. While much of this work falls to the provinces and territories\, there are five key things the federal government can do now. \n1. Planning: Add targets to measure progress in eliminating viral hepatitis to the 2025-2030 STBBI Action Plan.\nAn updated federal STBBI Action Plan was launched in January 2024. The plan excludes targets to measure Canada’s progress and inform federally funded projects. Targets are integral to an elimination plan. \n2. Testing: Update hepatitis C screening guidelines to be evidence-based\, develop evidence-based screening guidelines for hepatitis B\, and start offering free\, voluntary STBBI testing and linkage to care for all immigrants and newcomers.\nCanada’s hepatitis C screening guidelines recommend only screening people with certain risk factors\, despite all evidence that risk-based screening guidelines are ineffective at identifying chronic hepatitis C infections in time to avoid advanced liver disease or death. Canada does not have national hepatitis B screening guidelines at all\, resulting in many people being diagnosed at the same time they receive their liver cancer diagnosis. \n3. Testing-to-Treatment Link: Engage manufacturers of point-of-care testing technologies to bring these tests to Canada.\nHepatitis C is curable and hepatitis B is treatable. It takes several appointments to proceed from initial screening to starting treatment\, in part because point-of-care confirmatory testing technology used in other parts of the world is not yet available in Canada.\n​\n4. Prevention: Update NACI guidelines to recommend universal birth-dose hepatitis B vaccination.\nHepatitis B is vaccine-preventable. Canada is out of step with the WHO’s recommendation that even regions with low incidence of hepatitis B provide universal birth dose vaccination. Five provinces still offer the first publicly-funded doses of hepatitis B vaccine in school-based programs for ages 9-12\, which have a vaccination rate of ~70%\, missing the 90% WHO target. \n5. Data: Fund and increase efforts to collect updated hepatitis B and C prevalence estimates and population-specific cascades of care for all Canadian provinces and territories.\nIn order to measure our progress in viral hepatitis elimination\, we need reliable\, fulsome data about how many people are affected. \n\n\n\n\n\n\nSocial Media Graphics for Sharing\n\n\n\n\n\n\nThese graphics can be shared on social media with your own message and the hashtags #HepCantWait and #CanHepDay24.\n\n \n\n\nClick on the image to save it\n \n\nClick on the image to save it
URL:https://hepatology.ca/event/canadian-viral-hepatitis-elimination-day/
LOCATION:Ottawa\, Canada
CATEGORIES:Endorsed by CASL,In-Person
END:VEVENT
END:VCALENDAR